1. Multiple cyclic nucleotide phosphodiesterases;Beavo;Mol. Pharmacol.,1994
2. Phosphodiesterase inhibitors;Christensen,1996
3. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro;Hatzelmann;J. Pharmacol. Exp. Ther.,2001
4. Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity;Herman;Mol. Pharmacol.,2000
5. Characterization of the structure of a low Km, rolipram-sensitive cAMP phosphodiesterase. Mapping of the catalytic domain;Jin;J. Biol. Chem.,1992